BioCentury | Feb 2, 2018
Product Development

AA Viral meme

...trials that at lower doses, AAV is probably going to be surprisingly safe.” George Dickson, Royal Holloway University of London...
...Gelsinger received in that study. But George Dickson, a professor of molecular cell biology at Royal Holloway University of London...
...Muscular Dystrophy, Hackensack, N.J. Pfizer Inc. (NYSE:PFE), New York, N.Y. RegenxBio Inc. (NASDAQ:RGNX), Rockville, Md. Royal Holloway University of London...
BioCentury | Jan 19, 2018
Tools & Techniques

Synthetic expressions

Bringing synthetic biology to transcriptional regulation could catalyze a new generation of gene therapies that are more tunable, disease-specific and easy to deliver than the products dominating the field. The new constructs include synthetic promoters...
BioCentury | Oct 30, 2014
Distillery Therapeutics

Indication: Neurology

Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Epilepsy Not applicable In vitro and rodent studies suggest analogs of octanoic acid could help treat epilepsy. Chemical synthesis and electrophysiological testing in a rat...
BioCentury | Oct 30, 2014
Distillery Therapeutics

Indication: Neurology

Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Epilepsy Not applicable In vitro and rodent studies suggest analogs of octanoic acid could help treat epilepsy. Chemical synthesis and electrophysiological testing in a rat...
BioCentury | Sep 29, 2014
Emerging Company Profile

Ossianix: Shark teeth

...Preclinical Founded: 2012 by Frank Walsh, Corey Goodman, J. Lynn Rutkowski University collaborators: King's College, Royal Holloway University of London...
Items per page:
1 - 5 of 5
BioCentury | Feb 2, 2018
Product Development

AA Viral meme

...trials that at lower doses, AAV is probably going to be surprisingly safe.” George Dickson, Royal Holloway University of London...
...Gelsinger received in that study. But George Dickson, a professor of molecular cell biology at Royal Holloway University of London...
...Muscular Dystrophy, Hackensack, N.J. Pfizer Inc. (NYSE:PFE), New York, N.Y. RegenxBio Inc. (NASDAQ:RGNX), Rockville, Md. Royal Holloway University of London...
BioCentury | Jan 19, 2018
Tools & Techniques

Synthetic expressions

Bringing synthetic biology to transcriptional regulation could catalyze a new generation of gene therapies that are more tunable, disease-specific and easy to deliver than the products dominating the field. The new constructs include synthetic promoters...
BioCentury | Oct 30, 2014
Distillery Therapeutics

Indication: Neurology

Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Epilepsy Not applicable In vitro and rodent studies suggest analogs of octanoic acid could help treat epilepsy. Chemical synthesis and electrophysiological testing in a rat...
BioCentury | Oct 30, 2014
Distillery Therapeutics

Indication: Neurology

Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Epilepsy Not applicable In vitro and rodent studies suggest analogs of octanoic acid could help treat epilepsy. Chemical synthesis and electrophysiological testing in a rat...
BioCentury | Sep 29, 2014
Emerging Company Profile

Ossianix: Shark teeth

...Preclinical Founded: 2012 by Frank Walsh, Corey Goodman, J. Lynn Rutkowski University collaborators: King's College, Royal Holloway University of London...
Items per page:
1 - 5 of 5